The Changeover Pharmacy Care

The Changeover Pharmacy Care

AK Mohiuddin

Department of Pharmacy, World University of Bangladesh, Bangladesh

Global Journal of Library and Information Science

Medication-related issues are normal among home consideration patients who take numerous medications and have complex therapeutic narratives and medical issues. The objectives of home medicinal services administrations are to assist people with improving capacity and live with more noteworthy autonomy; to advance the customer’s ideal dimension of prosperity; and to help the patient to stay at home, evading hospitalization or admission to long haul care foundations. Home consideration is an arrangement of consideration given by gifted professionals to patients in their homes under the heading of a doctor. Home human services administrations incorporate nursing care; physical, word related, and discourse dialect treatment; and restorative social administrations. Doctors may allude patients for home social insurance administrations, or the administrations might be asked for by relatives or patients. The scope of home medicinal services benefits a patient can get at home is boundless. Contingent upon the individual patient’s circumstance, care can go from nursing care to particular restorative administrations, for example, research center workups. Basic judgments among home human services patients incorporate circulatory disease, heart disease, injury and poisoning, musculoskeletal and connective tissue disease and respiratory disease.

Abbreviations: Medicines Optimization in Care Homes (MOCH); Medication-related problems (MRPs); Residential Aged Care Home (RACH); Methicillin-resistant Staphylococcus aureus (MRSA); American Academy of Family Physicians (AAFP); International Association for Hospice and Palliative Care (IAHPC); Center to Advance Palliative Care (CAPC); Patient Centered Care (PCC); Length Of Stay (LOS), Length From Admission To Palliative Care Consult (LTC), Consult To Discharge Or Death (CTD); National Comprehensive Cancer Network (NCCN); Pediatric Palliative Care (PPC); National Hospice and Palliative Care Organization’s (NHPCO); Winnipeg Regional Health Authority (WRHA); Pharmacist Advancement of Transitions of Care to Home (PATCH); Home Medicines Review (HMR); Transition of Care (TOC); Chronic obstructive pulmonary disease (COPD); Acute Exacerbation of COPD (AECOPD); Low Health Literacy (LHL); Pharmacist Intervention for Low Literacy in Cardiovascular Disease” (PILL-CVD); Health-Related Quality of Life (HRQL); Heart failure (HF); Frequent Exacerbation (FEs); Emphysema Index (EI); Total Hip Arthroplasty (THA); Total Knee Arthroplasty (TKA), Total Joint Arthroplasty (TJA)

Keywords:  Transition Care; Pharmacist; Elderly; Home Care; Collaboration; Patients; Medicines

Free Full-text PDF

How to cite this article:
AK Mohiuddin.The Changeover Pharmacy Care. Global Journal of Library and Information Science, 2019, 2:10


1. Shannon R, Jenifer M, Tom L, Mary Ann B. The Role of a Pharmacist on the Home Care Team: A Collaborative Model Between a College of Pharmacy and a Visiting Nurse Agency. Home Healthcare Now February 2013, Volume 31 Number 2, p 80 – 87.
2. NHS England. Medicines optimisation in care homes. Available From:
3. Walus AN, Woloschuk DMM. Impact of Pharmacists in a Community-Based Home Care Service: A Pilot Program. Can J Hosp Pharm. 2017;70(6):435-442.
4. Wolstenholme B. Medication-Related Problems in Geriatric Pharmacology. Aging Well Vol. 4 No. 3 P. 8
5. Devik SA, Olsen RM, Fiskvik IL, Halbostad T, Lassen T, Kuzina N, Enmarker I. Variations in drug-related problems detected by multidisciplinary teams in Norwegian nursing homes and home nursing care. Scand J Prim Health Care. 2018 Sep;36(3):291-299. doi: 10.1080/02813432.2018.1499581. Epub 2018 Aug 23. PubMed PMID: 30139278.
6. Trang J, Martinez A, Aslam S, Duong MT. Pharmacist Advancement of Transitions of Care to Home (PATCH) Service. Hosp Pharm. 2015;50(11):994-1002.
7. Flanagan PS, Barns A. Current perspectives on pharmacist home visits: do we keep reinventing the wheel? Integrated Pharmacy Research and Practice 2018:7 141–159. DOI
8. McDerby N, Naunton M, Shield A, Bail K, Kosari S. Feasibility of Integrating Residential Care Pharmacists into Aged Care Homes to Improve Quality Use of Medicines: Study Protocol for a Non-Randomised Controlled Pilot Trial. Int J Environ Res Public Health. 2018;15(3):499.
9. Corsonello A, Pedone C, Incalzi RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Curr Med Chem. 2010;17(6):571-84. Review. PubMed PMID: 20015034.
10. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6-14.
11. Fernandez E, Perez R, Hernandez A, Tejada P, Arteta M, Ramos JT. Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults. Pharmaceutics. 2011;3(1):53-72. Published 2011 Feb 7. doi:10.3390/pharmaceutics3010053
12. Chen T.F. Pharmacist-led Home Medicines Review and Residential Medication Management Review: The Australian model. Drugs Aging. 2016;33:199–204. doi: 10.1007/s40266-016-0357-2.
13. Payne R.A., Abel G.A., Avery A.J., Mercer S.W., Roland M.O. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br. J. Clin. Pharmacol. 2014;77:1073–1082. doi: 10.1111/bcp.12292.
14. Tong E.Y., Roman C.P., Mitra B., Yip G.S., Gibbs H., Newnham H.H., Smit D.V., Galbraith K., Dooley M.J. Reducing medication errors in hospital discharge summaries: A randomised controlled trial. Med. J. Aust. 2017;206:36–39. doi: 10.5694/mja16.00628.
15. Deeks L.S., Cooper G.M., Draper B., Kurrle S., Gibson D.M. Dementia, medication and transitions of care. Res. Soc. Adm. Pharm. 2015;12:450–460. doi: 10.1016/j.sapharm.2015.07.002.
16. Ferrah N, Lovell JJ, Ibrahim JE. Systematic Review of the Prevalence of Medication Errors Resulting in Hospitalization and Death of Nursing Home Residents. J Am Geriatr Soc. 2017 Feb;65(2):433-442. doi: 10.1111/jgs.14683. Epub 2016 Nov 21. Review. PubMed PMID: 27870068.
17. Sugathan S, Singh D and others. Reported Prevalence And Risk Factors Of Chronic Non Communicable Diseases Among Inmates Of Old-Age Homes In Ipoh, Malaysia. International Journal of Preventive and Therapeutic Medicine Vol 2 (4) / OCT-DEC, 2014.
18. Simonetti AF, Viasus D, Garcia-Vidal C, Carratalà J. Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis. 2014;2(1):3-16.
19. Stevenson S. The 5 Most Common Infections in the Elderly. A Place For Mom Posted On 04 Aug 2017.
20. Cascini S, Agabiti N, Incalzi RA, et al. Pneumonia burden in elderly patients: a classification algorithm using administrative data. BMC Infect Dis. 2013;13:559. Published 2013 Nov 25. doi:10.1186/1471-2334-13-559
21. Manabe T, Teramoto S, Tamiya N, Okochi J, Hizawa N. Risk Factors for Aspiration Pneumonia in Older Adults. PLoS One. 2015;10(10):e0140060. Published 2015 Oct 7. doi:10.1371/journal.pone.0140060
22. CAPC Press Release. Palliative Care Continues Its Annual Growth Trend, According to Latest Center to Advance Palliative Care Analysis. February 28, 2018
23. Hofmeister M, Memedovich A, Dowsett LE, et al. Palliative care in the home: a scoping review of study quality, primary outcomes, and thematic component analysis. BMC Palliat Care. 2018;17(1):41. Published 2018 Mar 7. doi:10.1186/s12904-018-0299-z
24. Demler TL. Pharmacist Involvement in Hospice and Palliative Care. U.S. Pharmacist® March 17, 2016.
25. Medscape Pharmacists. Methadone, Pain Management, and Palliative Care. Available From:
26. American Society of Health-System Pharmacists. ASHP statement on the pharmacist’s role in hospice and palliative care. Am J Health Syst Pharm. 2002;59:1770-1773.
27. Lee HR, Yi SY, Kim DY. Evaluation of Prescribing Medications for Terminal Cancer Patients near Death: Essential or Futile. Cancer Res Treat. 2013;45(3):220-5.
28. Gonçalves F. Deprescription in Advanced Cancer Patients. Pharmacy (Basel). 2018;6(3):88. Published 2018 Aug 21. doi:10.3390/pharmacy6030088
29. Patel A, Dunmore-Griffith J, Lutz S, Johnstone PA. Radiation therapy in the last month of life. Rep Pract Oncol Radiother. 2013;19(3):191-4. Published 2013 Oct 16. doi:10.1016/j.rpor.2013.09.010
30. Masman AD, van Dijk M, Tibboel D, Baar FP, Mathôt RA. Medication use during end-of-life care in a palliative care centre. Int J Clin Pharm. 2015;37(5):767-775. doi: 10.1007/s11096-015-0094-3.
31. Del Fabbro E. Palliative care: assessment and management of nausea and vomiting. UpToDate website. Accessed August 23, 2016.
32. Grönheit W, Popkirov S, Wehner T, Schlegel U, Wellmer J. Practical Management of Epileptic Seizures and Status Epilepticus in Adult Palliative Care Patients. Front Neurol. 2018;9:595. Published 2018 Aug 2. doi:10.3389/fneur.2018.00595
33. Walker KA, Scarpaci L, McPherson ML. Fifty reasons to love your palliative care pharmacist. Am J Hosp Palliat Med. 2010;27(8):511-513. doi: 10.1177/10049909110371096.
34. Walker KA, Scarpaci L, McPherson ML. Fifty reasons to love your palliative care pharmacist. Am J Hosp Palliat Med. 2010;27(8):511-513. doi: 10.1177/10049909110371096.
35. Glare P, Miller J, Nikolova T, Tikoo R. Treating nausea and vomiting in palliative care: a review. Clin Interv Aging. 2011;6:243-259. doi: 10.2147/CIA.S13109.
36. Erichsén E, Milberg A, Jaarsma T, Friedrichsen MJ. Constipation in specialized palliative care: prevalence, definition, and patient-perceived symptom distress. J Palliat Med. 2015;18(7):585-592. doi: 10.1089/jpm.2014.0414.
37. Clark K, Smith JM, Currow DC. The prevalence of bowel problems reported in a palliative care population. J Pain Symptom Manage. 2012 Jun;43(6):993-1000. doi: 10.1016/j.jpainsymman.2011.07.015. PubMed PMID: 22651945.
38. Goodman M, Low J, Wilkinson S. Constipation management in palliative care: a survey of practices in the United Kingdom. J Pain Symptom Manage. 2005;29(3):238-244.
39. Wilson DM, Cohen J, Deliens L, Hewitt JA, Houttekier D. The preferred place of last days: results of a representative population-based public survey. J Palliat Med. 2013;16:502–508. doi: 10.1089/jpm.2012.0262.
40. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): palliative care. Published June 5, 2013.
41. National Collaborating Centre for Cancer (UK). Cardiff (UK). Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults. May 2012.
42. Atayee RS, Sam AM, Edmonds KP. Patterns of Palliative Care Pharmacist Interventions and Outcomes as Part of Inpatient Palliative Care Consult Service. J Palliat Med. 2018 Dec;21(12):1761-1767. doi: 10.1089/jpm.2018.0093. Epub 2018 Jun 29. PubMed PMID: 29957096.
43. Haggan M. Palliative care: Pharmacist breaks down roadblocks. News 26/05/2017.
44. Tait P, Morris B, To T. Core palliative medicines Meeting the needs of non-complex community patients. Australian Family Physician Volume 43, No.1, January/February 2014 Pages 29-32
45. Davis K, Schoenbaum SC, Audet AM. A 2020 vision of patient-centered primary care. J Gen Intern Med. 2005;20(10):953-7.
46. Jordan M, Keefer PM, Lee YA, Meade K, Snaman JM, Wolfe J, Kamal A, Rosenberg A. Top Ten Tips Palliative Care Clinicians Should Know About Caring for Children. J Palliat Med. 2018 Dec;21(12):1783-1789. doi: 10.1089/jpm.2018.0482. Epub 2018 Oct 5. PubMed PMID: 30289325.
47. National Hospice and Palliative Care Organization. Standards of Practice for Pediatric Palliative Care and Hospice. Available From:
48. Kristeller J. Transition of care: pharmacist help needed. Hosp Pharm. 2014;49(3):215-6.
49. Wick JY. Pharmacist Home Visits Improve Heart Failure Management. PharmacyTimes JULY 29, 2015
50. Anderson SL, Marrs JC. A Review of the Role of the Pharmacist in Heart Failure Transition of Care. Adv Ther. 2018;35(3):311-323.
51. Virginia Mason. Pharmacist House Calls Improve Health of Virginia Mason Heart Failure Patients. News Release March 11, 2016
52. Boylan P, Joseph T, Hale G, Moreau C, Seamon M, Jones R. Chronic Obstructive Pulmonary Disease and Heart Failure Self-Management Kits for Outpatient Transitions of Care. Consult Pharm. 2018 Mar 1;33(3):152-158. doi: 10.4140/TCP.n.2018.152. PubMed PMID: 29720300.
53. Nguyen TS, Nguyen TLH, Van Pham TT, Hua S, Ngo QC, Li SC. Pharmacists’ training to improve inhaler technique of patients with COPD in Vietnam. Int J Chron Obstruct Pulmon Dis. 2018;13:1863-1872. Published 2018 Jun 11. doi:10.2147/COPD.S163826
54. Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2):e010003. Published 2016 Feb 22. doi:10.1136/bmjopen-2015-010003
55. Aboumatar H, Naqibuddin M, Chung S, et al. Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial. JAMA. 2018;320(22):2335–2343. doi:10.1001/jama.2018.17933
56. Rinne ST, Lindenauer PK, Au DH. Intensive Intervention to Improve Outcomes for Patients With COPD. JAMA. 2018;320(22):2322–2324. doi:10.1001/jama.2018.17508
57. Rose L, Istanboulian L, Carriere L and others. Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD+): a randomised controlled trial. European Respiratory Journal Jan 2018, 51 (1) 1701567; DOI: 10.1183/13993003.01567-2017
58. van der Molen T, van Boven JF, Maguire T, Goyal P, Altman P. Optimizing identification and management of COPD patients – reviewing the role of the community pharmacist. Br J Clin Pharmacol. 2016;83(1):192-201.
59. Wei X, Ma Z, Yu N, et al. Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2017;13:121-129. Published 2017 Dec 27. doi:10.2147/COPD.S152826
60. Joseph Boyle, MD, Speroff T, Katherine Worley, MLIS, Aize Cao, PhD, Goggins K, Dittus RS, Kripalani S, Low Health Literacy Is Associated with Increased Transitional Care Needs in Hospitalized Patients. J. Hosp. Med 2017;11;918-924. Published online first September 20, 2017.. doi:10.12788/jhm.2841
61. Mansukhani RP, Bridgeman MB, Candelario D, Eckert LJ. Exploring Transitional Care: Evidence-Based Strategies for Improving Provider Communication and Reducing Readmissions. P T. 2015;40(10):690-4.
62. Batey C. The Pharmacist’s Role in Care for Elective Total Hip Arthroplasty/ Total Knee Arthroplasty. Transitions of Care America’s Pharmacist November 2016
63. Patton AP, Liu Y, Hartwig DM, May JR, Moon J, Stoner SC, Guthrie KD. Community pharmacy transition of care services and rural hospital readmissions: A case study. J Am Pharm Assoc (2003). 2017 May – Jun;57(3S):S252-S258.e3. doi: 10.1016/j.japh.2017.02.019. Epub 2017 Apr 12. PubMed PMID: 28412054.
64. Pharmacists implementing transitions of care in inpatient, ambulatory and community practice settings [UPDATED]. Pharm Pract (Granada). 2014;12(3):508.
65. Farris KB, Carter BL, Xu Y, et al. Effect of a care transition intervention by pharmacists: an RCT. BMC Health Serv Res. 2014;14:406. Published 2014 Sep 18. doi:10.1186/1472-6963-14-406
66. Louis AJ, Arora VM, Matthiesen MI, Meltzer DO, Press VG. Screening Hospitalized Patients for Low Health Literacy: Beyond the REALM of Possibility?. Health Educ Behav. 2016;44(3):360-364.
67. Rowlands G, Protheroe J, Winkley J, Richardson M, Seed PT, Rudd R. A mismatch between population health literacy and the complexity of health information: an observational study. Br J Gen Pract. 2015;65(635):e379-86.
68. Cawthon C, Walia S, Osborn CY, Niesner KJ, Schnipper JL, Kripalani S. Improving care transitions: the patient perspective. J Health Commun. 2012;17 Suppl 3(Suppl 3):312-24.
69. Kripalani S, Roumie CL, Dalal AK, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157(1):1-10.
70. Garza A. Transition of Care: An Opportunity for Community Pharmacists. PharmacyTimes December 22, 2017
71. Pharmacists can help reduce avoidable hospital admissions in the community. The Pharmaceutical Journal 9 October, 2013
72. Grissinger M. Reduce readmissions with pharmacy programs that focus on transitions from the hospital to the community. P T. 2015;40(4):232-3.

Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details).

This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.